000 01613 a2200397 4500
005 20250517205608.0
264 0 _c20191024
008 201910s 0 0 eng d
022 _a1523-4681
024 7 _a10.1002/jbmr.3427
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCosman, Felicia
245 0 0 _aFRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab.
_h[electronic resource]
260 _bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
_c07 2018
300 _a1219-1226 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aBone Density
650 0 4 _aDenosumab
_xtherapeutic use
650 0 4 _aFractures, Bone
_xepidemiology
650 0 4 _aHumans
650 0 4 _aOsteogenesis
650 0 4 _aRisk Factors
700 1 _aCrittenden, Daria B
700 1 _aFerrari, Serge
700 1 _aKhan, Aliya
700 1 _aLane, Nancy E
700 1 _aLippuner, Kurt
700 1 _aMatsumoto, Toshio
700 1 _aMilmont, Cassandra E
700 1 _aLibanati, Cesar
700 1 _aGrauer, Andreas
773 0 _tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
_gvol. 33
_gno. 7
_gp. 1219-1226
856 4 0 _uhttps://doi.org/10.1002/jbmr.3427
_zAvailable from publisher's website
999 _c28212474
_d28212474